As the Indian pharmaceutical Industry continues to grow with leaps and bounds, we at ORG ims strive towards being a one-stop shop for providing evidence based business solutions for healthcare companies.
The Indian pharma market is a complex environment within which 400 organized pharmaceutical companies promote around 47000 packs to more than 5 lakh doctors who generate nearly hundred crore prescriptions being honored at more than 2 lakh chemists.
The major points for any company to track its performance in this chaotic milieu starts right from a Medical Representative’s in-clinic performance to the realization of his efforts in the form of prescriptions generated from a doctor to the ultimate sales at the retail outlet or in institutions.
Our audits are specifically designed keeping the pharmaceutical companies’ requirements in mind and they provide a comprehensive means to track market performance on a monthly basis.
Our endeavor is to provide information solutions to our clients at each and every step of the value chain of the pharmaceutical market which is reflected in the illustration below.
Promo Monitor
Promotion Monitor is a business management tool, designed specifically to address the pharmaceutical industry’s need to better understand the interaction between doctors and medical representatives.
It helps in reviewing and monitoring the overall performance of companies and brands, analyzing the competitor activities, optimizing resource allocation, setting customer focused objectives, augmenting situational analyses, increasing the depth of understanding in developing SWOT analyses and broadening performance monitors to include competitive activity.
Currently Promo monitor is available for 2 specialties.
-
GP PM that monitors the in-clinic efficiency of medical representatives with general practitioners.
-
SPM CV, that monitors for cardiovascular specialists, including Cardiologists, Diabetologists and Consultant Physicians.
- For further information click here
Medical Audit
Medical Audit is a monthly audit that tracks prescriptions from 19 doctor specialists across four zones: North, South, East & West (Metro & Class 1 Cities). With a panel of 6000 Drs, this audit is an effective tracking tool to gauge the results of various strategies implemented in the field. It gives projected information of more than 2 lakh Drs and comes in a monthly format.
It maps trends across leading therapeutic segments, helps position products across specialties and co-prescription / prescriber loyalty analysis.
It enables cross-sectional analysis of prescriptions which include complete patient profile with age, gender, symptom & diagnosis, investigation and treatment regimen.
On the horizon is the regional medical audit that would give state wise information of the prescribing behavior of Drs.
- For further information click here
Stockist Secondary Audit
Stockist Secondary Audit is an audit which tracks the stockist sales to the retailer i.e. secondary sales.
It has a panel of more than 3000 stockists who cater to more than 50,000 retailers all across the country. The data is projected to give the sales figures of more than 300 companies all India. It has a validation of more than 85% as proven through various validation exercises with our clients.
It helps to identify potential therapeutic categories, monitoring performance of specific brands in relation to competing brands, segmenting the market by 4 zones, 18 states, 23 metros and all town classes.
- For further information click here
Hospital Secondary Audit (H S A)
ORG IMS’s Hospital Secondary Audit provides valuable information on the hospital segment, capturing sales from wholesalers to the various hospitals, and pharmacies within the vicinity of the hospitals on a quarterly basis.
The hospital segment constitutes 12% of the US$6.5 bn pharma market in India. The HSA covers 60% of the US$780 mn sales of pharmaceutical formulations to the hospitals in the country.
It has a panel of 1200 authorized Pharmaceutical stockists out of which 100 are specially hospital Stockists.
- For further information click here
IMS India Pharmaceutical Audit (IIPA)
IIPA tracks the primary sales of pharmaceutical companies on monthly basis through stockists purchase. It is a useful tool to track New Introductions and the reflection of Injectables is better as compared to SSA since they move primarily through the institutional chain.
- For further information click here
Index Track (XT)
The information in this audit is devised especially for financial institutions from the SSA on the performance of pharmaceutical companies.
Nepal Pharmaceutical Audit (NPI)
This is a unique marketing tool for information of the dynamics of the pharmaceutical industry in Nepal. NPI estimates performance of leading companies and their products and identifies areas where there are new opportunities.
Sri Lanka Pharmaceutical Audit (SLPA)
The Sri Lankan pharma market consists of retail pharmacies, government & private hospitals, dispensing doctors and institutions. It is estimated that retail pharmacies make up 65% of the total pharmaceutical market which is tracked by IMS. SLPA provides an accurate view for real demand of pharma products by tracking secondary sales on a monthly basis across the country.